Idealized PPARγ-based therapies : lessons from bench and bedside

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorAmato, Angélica Amorim-
Autor(es): dc.creatorNeves, Francisco de Assis Rocha-
Data de aceite: dc.date.accessioned2025-03-18T19:28:35Z-
Data de disponibilização: dc.date.available2025-03-18T19:28:35Z-
Data de envio: dc.date.issued2013-05-17-
Data de envio: dc.date.issued2013-05-17-
Data de envio: dc.date.issued2012-
Fonte completa do material: dc.identifierhttp://repositorio.unb.br/handle/10482/13143-
Fonte completa do material: dc.identifierhttps://dx.doi.org/10.1155/2012/978687-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/968817-
Descrição: dc.descriptionABSTRACT-
Descrição: dc.descriptionThe incidence of type 2 (T2D) diabetes and other chronic conditions associated with insulin resistance is increasing at an alarming rate, underscoring the need for effective and safe therapeutic strategies. Peroxisome-proliferator-activated receptor gamma (PPARγ) has emerged as a critical regulator of glucose homeostasis, lipid homeostasis, and vascular inflammation. Currently marketed drugs targeting this receptor, the thiazolidinediones (TZDs), have proven benefits on insulin resistance and hyperglycemia associated with T2D. Unfortunately, they have been associated with long-term unfavorable effects on health, such as weight gain, plasma volume expansion, bone loss, cardiovascular toxicity, and possibly cancer, and these safety concerns have led to reduced interest for many PPARγ ligands. However, over the last years, data from human genetic studies, animal models, and studies with ligands have increased our understanding of PPARγ’s actions and provided important insights into how ligand development strategies could be optimized to increase effectiveness and safety of PPARγ-based therapies.-
Formato: dc.formatapplication/pdf-
Publicador: dc.publisherHindawi Publishing Corporation-
Direitos: dc.rightsAcesso Aberto-
Direitos: dc.rightsCopyright © 2012 A. A. Amato and F. de Assis Rocha Neves. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Fonte: http://www.hindawi.com/journals/ppar/2012/978687/-
Palavras-chave: dc.subjectResistência à insulina-
Palavras-chave: dc.subjectMedicamentos - uso terapêutico-
Palavras-chave: dc.subjectDiabetes-
Título: dc.titleIdealized PPARγ-based therapies : lessons from bench and bedside-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional – UNB - Rep. 1

Não existem arquivos associados a este item.